Browsing by Author Nguyen, Huy Thang

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysisHackett, Maree; et al, Various; Forbes, John; Gommans, John; Graham, Catriona; Hankey, Graeme; Isaksson, Eva; Lewis, Steff; Lundstrom, Erik; Mead, Gillian; Nguyen, Huy Thang; The George Institute for Global HealthThe FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis, Trials, vol.18, 1, 2017,pp 1-11
2015Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentAnderson, Craig; Arima, Hisatomi; Chalmers, John; Chen, Xiaoying; Fuentes, Sully; Lindley, Richard; Woodward, Mark; et al, Various; Huang, Yining; Kim, Jong S.; Lavados, Pablo; Lee, Tsong-Hai; Levi, Christopher; Nguyen, Huy Thang; Olavarria, Veronica; Parsons, Mark; Robinson, Thompson; Sharma, Vijay K; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); The George Institute for Global HealthRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment, International Journal of Stroke, vol.10, 5, 2015,pp 778-788